Can a chatbot convince you to join a medical trial?
NCT ID NCT07305337
Summary
This study is testing whether an AI-powered chatbot can help patients with blood cancers like leukemia and lymphoma better understand clinical trials. Researchers want to see if this personalized, computer-based education increases patients' willingness to consider joining a trial. The goal is to find new ways to help patients make informed decisions about their care options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for LYMPHOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Zhongnan Hospital of Wuhan University
RECRUITINGWuhan, Hubei, 430071, China
Conditions
Explore the condition pages connected to this study.